Bioresorbable Implants Market Developments Sales Strategies insights 2022

Bioresorbable Implants Market Developments Sales Strategies insights 2022

The Bioresorbable Implants Market for bioresorbable implants is primarily driven by the growing cases of chronic diseases and the increasing geriatric population worldwide.

2021-05-24

Increasing Cases Of Chronic Diseases And Growing Geriatric Population 

The global market for bioresorbable implants is primarily driven by the growing cases of chronic diseases and the increasing geriatric population worldwide. According to the World Health Organization (WHO), it has been projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. 

The number of people in the developing world with diabetes will increase by more than 2.5-fold, from 84 million in 1995 to 228 million in 2025. On a global basis, 60% of the burden of chronic diseases will occur in developing countries. Indeed, cardiovascular diseases are even now more numerous in India and China than in all the economically developed countries in the world put together. As for overweight and obesity, not only has the current prevalence already reached unprecedented levels, but the rate at which it is annually increasing in most developing regions is substantial. 

The capability of bioresorbable implants to dissolve inside the body without the constraint of surgical removal is driving the acceptance of such implants in healthcare. Bioresorbable implants have started to gain traction due to its numerous applications such as orthopedic implants.

The increasing occurrence of orthopedic diseases and cancers, the increasing number of serious injuries, are driving the market growth in the forecast period.

There were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6 per cent in 1990 to 9% in 2019. Moreover, the upswing in demand for vaccine adjuvants can also be attributed to the prevalence of infectious diseases across the globe. 

It is estimated that around 9% of the population in the United States has been diagnosed with an infectious disease. Infectious diseases are caused by bacteria, viruses and other organisms and can be spread from person to person, through insect or animal bites, or through contaminated food or water. Some of the most common infectious diseases include HIV/AIDS, influenza, malaria, tuberculosis and hepatitis.

As per the US Centers for Disease Control and Prevention (CDC) data, there have been approximately 7 million influenza infections in the US in 2018, resulting in an estimated 84,000 hospitalizations. Also, in 2016, around 15.5 million infectious disease diagnosed patients visited hospital settings for primary treatment and disease management.

Advantages Of Biodegradable Implants

Bioresorbable implants degrade after completion of its function, which is considered as the major advantage of bioresorbable implants over the permanently installed devices.  Bioresorbable implants also bypasses the need of second surgery for the removal of the implant, making the process cost effective as compared to the non-biodegradable implants.  The orthopaedic implants market has witnessed a shift from conventional surgical procedures to the use of modern fixation and prosthetic devices.

The National Research Development Corporation (NRDC) — a technology transfer enterprise under the Department of Scientific & Industrial Research, Ministry of Science & Technology is considering a novel method to build biodegradable implant which is made of magnesium and hydroxyapatite.

The implant developed by the researchers of Lovely Professional University, gets auto degraded over a period of time, depending upon the PH level of human body. The orthopaedic implants market has witnessed a shift from conventional surgical procedures to the use of modern fixation and prosthetic devices. The demand for orthopaedic implants has increased significantly, owing to the rise in geriatric population that increases the risk of osteoporosis, osteoarthritis, and other musculoskeletal disorders.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

Found it interesting?

Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866

We have 5000+ marketing reports and serve across 130+ countries

Tags:

#bioresorbable implants market, #bioresorbable implants market size, #bioresorbable implants market share, #bioresorbable implants market trends, #bioresorbable implants market value, #bioresorbable implants market growth, #bioresorbable implants market demand, #shore power industry forecast, #bioresorbable implants market outlook, #bioresorbable implants market analysis, #bioresorbable implants market applications, #bioresorbable implants market companies, #covid-19, #datamintelligence